Clara Campàs is a venture capital investor at Asabys Partners who brings an unusually deep pharma industry background as a trained pharmacist with a PhD in pharmacology and over a decade of experience at companies like Almirall, where she served as Head of Corporate Development and Innovation leading strategy and M&A activities. She focuses heavily on digital therapeutics and behavior change, emphasizing patient psychology and engagement design alongside traditional molecular approaches, while maintaining a pharma corporate development mindset that evaluates startups based on their potential for eventual pharma partnerships and exits.